Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction

Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force

(2013) Mark Helfand et al.   ANNALS OF INTERNAL MEDICINE

Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3

(2013) Nina P. Paynter   ANNALS OF INTERNAL MEDICINE

C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force

(2013) David I. Buckley et al.   ANNALS OF INTERNAL MEDICINE

Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures

(2013) Nancy R. Cook et al.   ANNALS OF INTERNAL MEDICINE

Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)

(2010) Paul M. Ridker et al.   AMERICAN JOURNAL OF CARDIOLOGY

By Jove! What Is a Clinician to Make of JUPITER?

(2010) Sanjay Kaul   ARCHIVES OF INTERNAL MEDICINE

Separating the Contenders From the Pretenders

(2010) James A. de Lemos et al.   CIRCULATION

Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts

(2010) Stefan Blankenberg et al.   CIRCULATION

Arterial Stiffness and Cardiovascular Events

(2010) Gary F. Mitchell et al.   CIRCULATION

Cardiovascular Risk Prediction

(2010) Donald M. Lloyd-Jones   CIRCULATION

Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction

(2010) Tamar S. Polonsky   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

What Makes a Good Predictor?

(2010) John P. A. Ioannidis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Multiple Biomarkers for Predicting Cardiovascular Events

(2010) Thomas J. Wang   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis

(2010) Raimund Erbel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly

(2010) Suzette E. Elias-Smale et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness

(2010) Charalambos Vlachopoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

(2010)   LANCET

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Clinical and Research Applications of Carotid Intima-Media Thickness

(2009) Kavita Sharma et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Value of Carotid Intima-Media Thickness for Predicting Cardiovascular Risk

(2009) Alain Simon et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: The Caerphilly Study

(2009) Christopher C. Patterson et al.   ATHEROSCLEROSIS

Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

(2009) Muriel J. Caslake et al.   ATHEROSCLEROSIS

B-Type Natriuretic Peptides and Cardiovascular Risk

(2009) Emanuele Di Angelantonio et al.   CIRCULATION

Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits

(2009) Tomonari Koike et al.   CIRCULATION

C-Reactive Protein and Coronary Disease

(2009) John Danesh et al.   CIRCULATION

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study

(2009) Joseph Yeboah et al.   CIRCULATION

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease

(2009) Paul Elliott   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial

(2009)   LANCET

Can the polypill save the world from heart disease?

(2009) Christopher P Cannon   LANCET

New susceptibility locus for coronary artery disease on chromosome 3q22.3

(2009) Jeanette Erdmann et al.   NATURE GENETICS

Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease

(2009) David-Alexandre Trégouët et al.   NATURE GENETICS

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

(2009) Sekar Kathiresan et al.   NATURE GENETICS

Elements of Danger — The Case of Medical Imaging

(2009) Michael S. Lauer   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

(2009) Robert Clarke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness

(2009) Allen J. Taylor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Coronary Artery Calcification Compared With Carotid Intima-Media Thickness in the Prediction of Cardiovascular Disease IncidenceThe Multi-Ethnic Study of Atherosclerosis (MESA)

(2008) Aaron R. Folsom   ARCHIVES OF INTERNAL MEDICINE

C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study

(2008) Peter W.F. Wilson et al.  

The Use of Genomics in Clinical Trial Design

(2008) R. Simon   CLINICAL CANCER RESEARCH

Randomized Phase III Clinical Trial Designs for Targeted Agents

(2008) A. Hoering et al.   CLINICAL CANCER RESEARCH

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The search for new cardiovascular biomarkers

(2008) Robert E. Gerszten et al.   NATURE

Expanding the Orbit of Primary Prevention — Moving beyond JUPITER

(2008) Mark A. Hlatky   NEW ENGLAND JOURNAL OF MEDICINE

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

(2008) Björn Zethelius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events

(2008) Sekar Kathiresan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease

(2008) Jeppe Zacho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biomarkers for cardiovascular disease: challenges and future directions

(2008) Abigail May et al.   TRENDS IN MOLECULAR MEDICINE

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

(2008) John Danesh et al.   PLOS MEDICINE

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice

(2007) Glenys A. Tennent et al.   ATHEROSCLEROSIS